Inulin Fiber and a High-Fat Meal in Metabolically Healthy Obesity
Tests how inulin fiber and a fatty meal affect gut and blood vessels.
Key facts
- Who runs it
- Ball State University
- Where
- Muncie, United StatesSee the site
- Trial code
- Registry title
- Gut, Immune, and Vascular Health in Metabolically Healthy Obesity
- Status
- Recruiting
- People taking part
- 70 people, planned
- Started
- 1 Mar 2026
- Expected to end
- Dec 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Inulin Supplementation
- Maltodextrin (Placebo)
- High-fat meal
- Record updated
- 30 April 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-55 who are metabolically healthy, either with obesity or with normal weight. They will have a high-fat meal, and some with obesity will also take a fiber supplement.
- Age
- 18 to 55 years
- Sex
- All sexes can join. Women cannot be pregnant, expecting to become pregnant, or postmenopausal.
- Disease stage
- Obesity (BMI over 30 kg/m2) or normal weight (BMI 18.5-24.9 kg/m2), with 0-1 risk factors based on blood pressure, blood sugar, triglycerides and HDL-cholesterol. No advanced heart or metabolic disease.
- Earlier treatment
- No antibiotics or probiotics in the last month. No lipid-lowering, glucose-lowering, anti-hypertensive or weight-loss drugs. No surgery that alters the stomach or gut. Regular anti-inflammatory drugs must be paused 3 days before the visit.
- Biomarker or test result
- 0-1 risk factors among blood pressure, blood sugar, triglycerides and HDL-cholesterol.
Main reasons for not taking part
- Advanced heart or metabolic condition such as cardiovascular disease or type 2 diabetes
- Chronic inflammatory or gut condition such as rheumatoid arthritis or inflammatory bowel disease
- Use of tobacco or illicit drugs
- Pacemaker
- Diet that prevents eating the provided meal, such as vegan, vegetarian or gluten-free diet, or food allergies
The registry criteria, word for word
Show all 32 criteriaShow less
Who can take part
- 18-55 years old
- BMI is 18.5-24.9 kg/m2 or >30kg/m2 (part 1). BMI > 30 kg/m2 (part 2)
- Not pregnant or expecting to become pregnant (females only)
- Not postmenopausal (females only)
- Have 0-1 risk factors based on blood pressure, blood sugar, triglycerides, and HDL-cholesterol ("good cholesterol")
- Have not been diagnosed with an advanced cardiometabolic condition (e.g., cardiovascular disease, type 2 diabetes)
- Have not been diagnosed with a chronic inflammatory or gastrointestinal condition (e.g., rheumatoid arthritis, inflammatory bowel disease)
- Do not regularly take anti-inflammatory drugs (more than 2x week) or are able to temporarily suspend use of anti-inflammatory drugs three days prior to the study visit
- Have not taken antibiotics or probiotics in the last month
- Do not use lipid-lowering drugs (e.g., statins), glucose-lowering drugs (e.g., metformin), or anti-hypertensive drugs
- Do not use weight-loss drugs (e.g., Ozempic, Wegovy)
- Have not had any surgery that alters the stomach/gastrointestinal tract (e.g., gastric sleeve, gastric bypass)
- Do not use tobacco products or any illicit drugs
- Do not have a pacemaker
- Do not have dietary restrictions prohibiting consumption of the provided meal (e.g., vegan/vegetarian diets, gluten-free diet, relevant food allergies)
- Able to stay in the supine position in the dark for at least 10 minutes (related to vascular measurements)
Who cannot take part
- Regularly take anti-inflammatory drugs (more than 2x week) or are unable to temporarily suspend use of anti-inflammatory drugs three days prior to the study visit
- Use weight-loss drugs (e.g., Ozempic, Wegovy)
- Have had any surgery that alters the stomach/gastrointestinal tract (e.g., gastric sleeve, gastric bypass)
- Use tobacco products or any illicit drugs
- Have been diagnosed with an advanced cardiometabolic condition (e.g., cardiovascular disease, type 2 diabetes)
- Have been diagnosed with a chronic inflammatory or gastrointestinal condition (e.g., rheumatoid arthritis, inflammatory bowel disease)
- Have dietary restrictions prohibiting consumption of the provided meal (e.g., vegan/vegetarian diets, gluten-free diet, relevant food allergies)
- Use lipid-lowering drugs (e.g., statins), glucose-lowering drugs (e.g., metformin), or anti-hypertensive drugs
- Not 18-55 years old
- BMI is not 18.5-24.9 kg/m2 or >30kg/m2 (part 1). BMI is not > 30 kg/m2 (part 2)
- Pregnant or expecting to become pregnant (females only)
- Postmenopausal (females only)
- Do not have 0-1 risk factors based on blood pressure, blood sugar, triglycerides, and HDL-cholesterol ("good cholesterol")
- Have taken antibiotics or probiotics in the last month
- Have a pacemaker
- Not able to stay in the supine position in the dark for at least 10 minutes (related to vascular measurements)
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
Where in United States
- Health Professions BuildingMuncie, United StatesContact: Bryant Keirns, PhDTaking people
About the trial
What the trial wants to find out
The investigators seek to better understand how a single high-fat meal impacts gut, immune, and vascular outcomes in individuals with "metabolically healthy obesity" (obesity and largely normal cardiometabolic profile) and "metabolically healthy normal-weight individuals." Second, the investigators seek to understand how a prebiotic fiber (inulin) impacts gut, immune, and vascular outcomes in individuals with "metabolically healthy obesity."
The 2 groups in the trial
- Metabolically Healthy Obesity GroupTreatment being tested
Individuals with a body mass index greater than 30 kg/m2 and 0-1 of the following risk factors: blood pressure \>130/85 mmHg, triglycerides \> 150 mg/dL, glucose \> 100 mg/dL, and HDL-C \< 50 (females) or \< 40 (males).
Treatment: Inulin Supplementation, Maltodextrin (Placebo), and High-fat meal
- Metabolically Healthy Normal Weight GroupExisting treatment, for comparison
Individuals with a body mass index between 18.5-24.9 kg/m2 and 0-1 of the following risk factors: blood pressure \>130/85 mmHg, triglycerides \> 150 mg/dL, glucose \> 100 mg/dL, and HDL-C \< 50 (females) or \< 40 (males).
Treatment: High-fat meal
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Impaired Gut-Vascular Axis as a Unique Driver of Cardiovascular Disease in Metabolically Healthy Obesity
- Plain-language title
- Inulin Fiber and a High-Fat Meal in Metabolically Healthy ObesityGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Fit questions
- Built from NCT07559227, who can take part
- Record updated
- 30 April 2026